Results 111 to 120 of about 337,805 (303)

Clinical Significance of PD‐L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This study evaluated immune‐related biomarkers in esophageal squamous cell carcinoma treated with immune checkpoint inhibitors after postoperative recurrence. PD‐L1 expression in tumor‐associated macrophages and tumor cells, together with HLA class I downregulation and HLA‐DR expression, were associated with favorable responses to immunotherapy.
Kosuke Kanemitsu   +9 more
wiley   +1 more source

Concurrent incidence of esophageal squamous cell carcinoma and gastric adenocarcinoma: a report of three cases

open access: yesСибирский онкологический журнал
The purpose of the study was to investigate rare cases of concurrent incidence of esophageal squamous cell carcinoma and gastric adenocarcinoma to develop an effective treatment strategy.Material and Methods. Herein, we present a report of three cases of
E. A. Toneev   +7 more
doaj   +1 more source

Esophageal Squamous Cell Carcinoma With Colonic Metastases

open access: yesACG Case Reports Journal, 2020
ABSTRACT Esophageal squamous cell carcinoma (ESCC) is recognized as one of the most lethal malignancies worldwide. The disease's tendency to quickly metastasize precludes many patients from receiving curative therapy. The most common sites of distal metastases include the liver, lungs, bones, and brain.
Wiseman, Daniel   +4 more
openaire   +2 more sources

Systematic Review and Meta‐Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This meta‐analysis of 208 cases shows that salvage esophagectomy for cT4 esophageal squamous cell carcinoma achieves a 72% R0 resection rate, offering a curative pathway for selected patients. However, it remains a high‐risk procedure with an 18% anastomotic leak rate and 30% major complications (Clavien–Dindo ≥ III).
Makoto Sakai   +4 more
wiley   +1 more source

Pancreatic Metastases of Esophageal Squamous Cell Carcinoma: A Case Report and Review of the Literature

open access: yesDiagnostics
Esophageal carcinoma is an aggressive cancer with a poor therapeutic response and a significant risk of recurrence after radical resection. It usually metastasizes to the lung, bones, or liver.
Tivadar Bara   +7 more
doaj   +1 more source

Multidisciplinary Treatment for Esophagogastric Junction Cancer From a Dutch Perspective

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Esophagogastric junction (EGJ) cancer is an increasing health burden worldwide. Over the past decade, significant advancements in centralization, multimodal treatment strategies, as well as the widespread adoption of minimally invasive surgical techniques, have led to marked improvements in perioperative outcomes and overall survival of EGJ ...
Hidde C. G. Overtoom   +1 more
wiley   +1 more source

Esophageal Squamous Cell Carcinoma

open access: yes
This chapter discusses new developments in the detection, staging, and treatment of esophageal squamous cell carcinoma (ESCC) worldwide over the past 15 years, as well as the differences between Eastern and Western approaches. With regards to clinical and pathological staging, both the TNM staging system developed by the International Union against ...
Van Der Zijden, Charlène J.   +14 more
openaire   +3 more sources

Antioxidant, cytotoxicity, anti-human esophageal squamous cell carcinoma, anti-human Caucasian esophageal carcinoma, anti-adenocarcinoma of the gastroesophageal junction, and anti-distal esophageal adenocarcinoma properties of gold nanoparticles green synthesized by Rhus coriaria L. fruit aqueous ex

open access: yes, 2020
Every year, many people die due to cancer in all of the world. So, the preparation and formulation of new chemotherapeutic supplements and drugs with remarkable effects for the treatment of cancer are in the priority of both developing and developed ...
Jin Liu   +3 more
semanticscholar   +1 more source

Return‐To‐Work and Working Status After Surgery for Gastric and Esophageal Cancer: A Prospective Observational Study

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
In this multicenter prospective study of 158 working‐age patients undergoing curative‐intent surgery for gastric or esophageal cancer, 78.5% were working at 18 months. Postoperative appetite loss, financial difficulties, and ≥ 10% weight loss at 6 months were associated with non‐working status.
Kentaro Goto   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy